Literature DB >> 28057474

HIV-1 Tat disrupts blood-brain barrier integrity and increases phagocytic perivascular macrophages and microglia in the dorsal striatum of transgenic mice.

Crystal R Leibrand1, Jason J Paris2, M Said Ghandour3, Pamela E Knapp4, Woong-Ki Kim5, Kurt F Hauser4, MaryPeace McRae6.   

Abstract

HIV-1 infection results in blood-brain barrier (BBB) disruption, which acts as a rate-limiting step for HIV-1 entry into the CNS and for subsequent neuroinflammatory/neurotoxic actions. One mechanism by which HIV may destabilize the BBB involves actions of the HIV-1 regulatory protein, trans-activator of transcription (Tat). We utilized a conditional, Tat-expressing transgenic murine model to examine the influence of Tat1-86 expression on BBB integrity and to assess the relative numbers of phagocytic perivascular macrophages and microglia within the CNS in vivo. The effects of Tat exposure on sodium-fluorescein (Na-F; 0.376kDa), horseradish peroxidase (HRP; 44kDa), and Texas Red-labeled dextran (70kDa) leakage into the brain were assessed in Tat-exposed (Tat+) and control (Tat-) mice. Exposure to HIV-1 Tat significantly increased both Na-F and HRP, but not the larger sized Texas Red-labeled dextran, confirming BBB breakdown and also suggesting the breach was limited to molecules <70kDa. Additionally, at 5 d after Tat induction, Alexa Fluor® 488-labeled dextran was bilaterally infused into the lateral ventricles 5 d before the termination of the experiment. Within the caudate/putamen, Tat induction increased the proportion of dextran-labeled Iba-1+ phagocytic perivascular macrophages (∼5-fold) and microglia (∼3-fold) compared to Tat- mice. These data suggest that HIV-1 Tat exposure is sufficient to destabilize BBB integrity and to increase the presence of activated, phagocytic, perivascular macrophages and microglia in an in vivo model of neuroAIDS.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Blood-brain barrier; Caudate/putamen; Human immunodeficiency virus; Microglia; Perivascular macrophages; Trans-activator of transcription

Mesh:

Substances:

Year:  2017        PMID: 28057474      PMCID: PMC5401762          DOI: 10.1016/j.neulet.2016.12.073

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  58 in total

1.  CCL2/monocyte chemoattractant protein-1 mediates enhanced transmigration of human immunodeficiency virus (HIV)-infected leukocytes across the blood-brain barrier: a potential mechanism of HIV-CNS invasion and NeuroAIDS.

Authors:  Eliseo A Eugenin; Kristin Osiecki; Lillie Lopez; Harris Goldstein; Tina M Calderon; Joan W Berman
Journal:  J Neurosci       Date:  2006-01-25       Impact factor: 6.167

2.  The susceptibility of macrophages to human immunodeficiency virus type 1 X4 isolates depends on their activation state.

Authors:  Y Bakri; S Amzazi; A Mannioui; A Benjouad
Journal:  Biomed Pharmacother       Date:  2001-02       Impact factor: 6.529

Review 3.  Cell death in HIV dementia.

Authors:  M P Mattson; N J Haughey; A Nath
Journal:  Cell Death Differ       Date:  2005-08       Impact factor: 15.828

4.  Interactive comorbidity between opioid drug abuse and HIV-1 Tat: chronic exposure augments spine loss and sublethal dendritic pathology in striatal neurons.

Authors:  Sylvia Fitting; Ruqiang Xu; Cecilia Bull; Shreya K Buch; Nazira El-Hage; Avindra Nath; Pamela E Knapp; Kurt F Hauser
Journal:  Am J Pathol       Date:  2010-07-22       Impact factor: 4.307

5.  Phenotypic changes of monocytes induced by HIV-1 gp120 molecule and its fragments.

Authors:  M Zembala; S Bach; A Szczepanek; G Mancino; V Colizzi
Journal:  Immunobiology       Date:  1997-06       Impact factor: 3.144

Review 6.  Monocyte maturation, HIV susceptibility, and transmigration across the blood brain barrier are critical in HIV neuropathogenesis.

Authors:  Dionna W Williams; Eliseo A Eugenin; Tina M Calderon; Joan W Berman
Journal:  J Leukoc Biol       Date:  2012-01-06       Impact factor: 4.962

Review 7.  Role of mononuclear phagocytes in the pathogenesis of human immunodeficiency virus infection.

Authors:  M S Meltzer; D R Skillman; P J Gomatos; D C Kalter; H E Gendelman
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

8.  Human immunodeficiency virus type 1 gp120-mediated disruption of tight junction proteins by induction of proteasome-mediated degradation of zonula occludens-1 and -2 in human brain microvascular endothelial cells.

Authors:  Shinichi Nakamuta; Hiroshi Endo; Youichiro Higashi; Aoi Kousaka; Hiroshi Yamada; Mihiro Yano; Hiroshi Kido
Journal:  J Neurovirol       Date:  2008-05       Impact factor: 2.643

9.  5α-reduced progestogens ameliorate mood-related behavioral pathology, neurotoxicity, and microgliosis associated with exposure to HIV-1 Tat.

Authors:  Jason J Paris; ShiPing Zou; Yun K Hahn; Pamela E Knapp; Kurt F Hauser
Journal:  Brain Behav Immun       Date:  2016-01-13       Impact factor: 7.217

10.  Blood-brain barrier abnormalities in the acquired immunodeficiency syndrome: immunohistochemical localization of serum proteins in postmortem brain.

Authors:  C K Petito; K S Cash
Journal:  Ann Neurol       Date:  1992-11       Impact factor: 10.422

View more
  21 in total

1.  HIV-1 Tat and opioids act independently to limit antiretroviral brain concentrations and reduce blood-brain barrier integrity.

Authors:  Crystal R Leibrand; Jason J Paris; Austin M Jones; Quamrun N Masuda; Matthew S Halquist; Woong-Ki Kim; Pamela E Knapp; Angela D M Kashuba; Kurt F Hauser; MaryPeace McRae
Journal:  J Neurovirol       Date:  2019-05-17       Impact factor: 2.643

Review 2.  The impact of substance abuse on HIV-mediated neuropathogenesis in the current ART era.

Authors:  Vanessa Chilunda; Tina M Calderon; Pablo Martinez-Aguado; Joan W Berman
Journal:  Brain Res       Date:  2019-08-29       Impact factor: 3.252

3.  CCR5 mediates HIV-1 Tat-induced neuroinflammation and influences morphine tolerance, dependence, and reward.

Authors:  Maciej Gonek; Virginia D McLane; David L Stevens; Kumiko Lippold; Hamid I Akbarali; Pamela E Knapp; William L Dewey; Kurt F Hauser; Jason J Paris
Journal:  Brain Behav Immun       Date:  2017-11-13       Impact factor: 7.217

4.  Characterization of cell-cell junction changes associated with the formation of a strong endothelial barrier.

Authors:  MaryPeace McRae; Lindsay M LaFratta; Benjamin M Nguyen; Jason J Paris; Kurt F Hauser; Daniel E Conway
Journal:  Tissue Barriers       Date:  2018-02-01

5.  Age-Related Decrease in Tyrosine Hydroxylase Immunoreactivity in the Substantia Nigra and Region-Specific Changes in Microglia Morphology in HIV-1 Tg Rats.

Authors:  David R Goulding; Andrew Kraft; Peter R Mouton; Christopher A McPherson; Valeria Avdoshina; Italo Mocchetti; G Jean Harry
Journal:  Neurotox Res       Date:  2019-07-08       Impact factor: 3.911

6.  HIV Tat causes synapse loss in a mouse model of HIV-associated neurocognitive disorder that is independent of the classical complement cascade component C1q.

Authors:  Jennetta W Hammond; Wen Q Qiu; Daniel F Marker; Jeffrey M Chamberlain; Will Greaves-Tunnell; Matthew J Bellizzi; Shao-Ming Lu; Harris A Gelbard
Journal:  Glia       Date:  2018-10-16       Impact factor: 7.452

Review 7.  Cure and Long-Term Remission Strategies.

Authors:  Luisa Mori; Susana T Valente
Journal:  Methods Mol Biol       Date:  2022

8.  Methamphetamine augment HIV-1 Tat mediated memory deficits by altering the expression of synaptic proteins and neurotrophic factors.

Authors:  Anantha Ram Nookala; Daniel C Schwartz; Nitish S Chaudhari; Alexy Glazyrin; Edward B Stephens; Nancy E J Berman; Anil Kumar
Journal:  Brain Behav Immun       Date:  2018-05-02       Impact factor: 7.217

9.  Effects of HIV-1 Tat and Methamphetamine on Blood-Brain Barrier Integrity and Function In Vitro.

Authors:  Sulay Patel; Crystal R Leibrand; Preetha Palasuberniam; Pierre-Olivier Couraud; Babette Weksler; Fay M Jahr; Joseph L McClay; Kurt F Hauser; MaryPeace McRae
Journal:  Antimicrob Agents Chemother       Date:  2017-11-22       Impact factor: 5.191

10.  The protective effect of gastrodin against the synergistic effect of HIV-Tat protein and METH on the blood-brain barrier via glucose transporter 1 and glucose transporter 3.

Authors:  Juan Li; Jian Huang; Yongwang He; Wenguang Wang; Chi-Kwan Leung; Dongxian Zhang; Ruilin Zhang; Shangwen Wang; Yuanyuan Li; Liu Liu; Xiaofeng Zeng; Zhen Li
Journal:  Toxicol Res (Camb)       Date:  2021-01-22       Impact factor: 3.524

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.